Astera Labs (NASDAQ:ALAB) Issues Q2 2026 Earnings Guidance

Astera Labs (NASDAQ:ALAB) issued an update on its second quarter 2026 earnings guidance on Tuesday morning. The company provided EPS guidance of 0.680-0.700 for the period, compared to the consensus EPS estimate of 0.500. The company issued revenue guidance of $355.0 million-$365.0 million, compared to the consensus revenue estimate of $310.0 million.

Astera Labs Stock Down 8.5%

ALAB traded down $18.26 during trading on Thursday, hitting $195.65. 6,522,741 shares of the company’s stock were exchanged, compared to its average volume of 6,304,255. Astera Labs has a fifty-two week low of $69.26 and a fifty-two week high of $262.90. The stock has a market cap of $33.51 billion, a P/E ratio of 158.45, a PEG ratio of 4.21 and a beta of 3.35. The business’s 50 day moving average is $142.43 and its two-hundred day moving average is $153.74.

Astera Labs (NASDAQ:ALAB) last released its quarterly earnings data on Tuesday, May 5th. The company reported $0.61 earnings per share for the quarter, beating analysts’ consensus estimates of $0.54 by $0.07. Astera Labs had a net margin of 26.72% and a return on equity of 19.36%. The firm had revenue of $308.36 million for the quarter, compared to analyst estimates of $292.19 million. During the same period last year, the firm earned $0.33 earnings per share. The business’s quarterly revenue was up 93.5% compared to the same quarter last year. Astera Labs has set its Q2 2026 guidance at 0.680-0.700 EPS. On average, sell-side analysts forecast that Astera Labs will post 1.48 earnings per share for the current year.

Analysts Set New Price Targets

ALAB has been the topic of a number of recent research reports. Roth Mkm reaffirmed a “buy” rating and issued a $275.00 price objective on shares of Astera Labs in a research note on Wednesday. UBS Group initiated coverage on shares of Astera Labs in a research note on Tuesday, April 21st. They issued a “neutral” rating and a $180.00 price objective on the stock. Jefferies Financial Group reaffirmed a “buy” rating and issued a $270.00 price objective on shares of Astera Labs in a research note on Wednesday. Rothschild & Co Redburn initiated coverage on shares of Astera Labs in a research note on Friday, May 1st. They issued a “neutral” rating and a $153.00 price objective on the stock. Finally, TD Cowen raised their price objective on shares of Astera Labs from $140.00 to $225.00 and gave the company a “hold” rating in a research note on Wednesday. Fifteen research analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the company. According to MarketBeat.com, Astera Labs presently has a consensus rating of “Moderate Buy” and an average target price of $229.65.

Insider Activity

In other news, General Counsel Philip Mazzara sold 10,000 shares of the stock in a transaction dated Wednesday, April 1st. The shares were sold at an average price of $107.77, for a total value of $1,077,700.00. Following the completion of the sale, the general counsel owned 118,084 shares in the company, valued at $12,725,912.68. This represents a 7.81% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Jitendra Mohan sold 10,188 shares of the stock in a transaction dated Monday, April 20th. The shares were sold at an average price of $175.45, for a total transaction of $1,787,484.60. Following the completion of the sale, the chief executive officer owned 4,069,134 shares of the company’s stock, valued at approximately $713,929,560.30. This represents a 0.25% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last three months, insiders have sold 1,064,888 shares of company stock worth $150,764,723. Company insiders own 12.50% of the company’s stock.

Astera Labs News Summary

Here are the key news stories impacting Astera Labs this week:

• Positive Sentiment: Q1 results materially beat expectations — revenue nearly doubled, EPS beat, gross margins expanded and management raised Q2 guidance; company highlighted strong PCIe‑6 and AI connectivity demand (Scorpio/X-series momentum). ALAB Q1 Earnings Beat
• Positive Sentiment: Multiple brokerages raised targets/ratings this week (JPMorgan to $280/Overweight; Needham and Stifel to $260; Susquehanna raised target) — institutional research is now more bullish, giving the stock additional upside case. JPMorgan Boost Needham Raise
• Positive Sentiment: Analyst/commentary pieces emphasize Astera’s strategic position in AI/datacenter internal connectivity and a strong product roadmap (X‑series, optical plans) that should support multi‑year growth. MarketBeat: AI Connectivity Seeking Alpha Q1 Take
• Neutral Sentiment: Earnings-call detail and transcripts are available for investors wanting depth on product cadence, gross‑margin outlook and inventory comments. Earnings Call Transcript
• Neutral Sentiment: Market coverage summaries and headlines captured the post‑earnings momentum but reflect a fast-moving narrative that can flip with short-term flows. TipRanks Highlights MarketWatch
• Negative Sentiment: Valuation and risk concerns: analysts and commentaries warn that ALAB now trades at a premium (high P/E and PEG) and that rising costs, competition and execution risk could limit upside — a common reason for short‑term selling or profit-taking. Zacks Caution
• Negative Sentiment: Third‑party pieces question whether the recent run-up has left the stock stretched relative to fundamentals, which increases the risk of a pullback on heavy volume. Yahoo: Overvaluation

Institutional Trading of Astera Labs

Several institutional investors and hedge funds have recently made changes to their positions in ALAB. Great Valley Advisor Group Inc. increased its holdings in Astera Labs by 2.2% during the second quarter. Great Valley Advisor Group Inc. now owns 4,119 shares of the company’s stock worth $372,000 after buying an additional 90 shares during the last quarter. National Bank of Canada FI increased its holdings in Astera Labs by 159.0% during the third quarter. National Bank of Canada FI now owns 202 shares of the company’s stock worth $39,000 after buying an additional 124 shares during the last quarter. Smartleaf Asset Management LLC increased its holdings in Astera Labs by 422.2% during the fourth quarter. Smartleaf Asset Management LLC now owns 188 shares of the company’s stock worth $32,000 after buying an additional 152 shares during the last quarter. Prosperity Wealth Management Inc. increased its holdings in Astera Labs by 4.1% during the third quarter. Prosperity Wealth Management Inc. now owns 4,300 shares of the company’s stock worth $842,000 after buying an additional 168 shares during the last quarter. Finally, State of Wyoming increased its holdings in Astera Labs by 29.1% during the fourth quarter. State of Wyoming now owns 826 shares of the company’s stock worth $137,000 after buying an additional 186 shares during the last quarter. Hedge funds and other institutional investors own 60.47% of the company’s stock.

Astera Labs Company Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.